Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Author： Plaxe S.C. Blessing J.A. Husseinzadeh N. Webster K.D. Rader J.S. Dunton C.J.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.2, 2002-02, pp. : 241-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Miller D.S. Blessing J.A. Lentz S.S. Waggoner S.E.

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 247-251

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G. Brunetto V.L. VanLe L. Bell J. Walker J.L. Lee R.B.

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 212-216

Elsevier

Access to resources Recommend Favorite

Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study

By Covens A. Brunetto V.L. Markman M. Orr J.W. Lentz S.S. Benda J.

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 470-474

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study

By Plaxe S.C. Blessing J.A. Bookman M.A. Creasman W.T.

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 32-35

Elsevier

Access to resources Recommend Favorite

Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group

By Moore D.H. Blessing J.A. Dunton C. Buller R.E. Reid G.C.

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 473-475

Elsevier

Access to resources Recommend Favorite